Home > Insider Trading > Filing (0001516551-24-000117)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516551	Skye Bioscience Inc.	SKYE	Pharmaceutical Preparations (2834)	450692882

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1877242	Kaitlyn Arsenault	11250 El Camino Real, Suite 100 C/O Skye Bioscience, Inc. San Diego CA 92130	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-11-15	190	$5.55	209,548	No	4	S	Direct
Common Stock	Disposition	2024-11-18	43,206	$4.99	166,342	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance-based restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the Reporting Person.
The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $4.98 to $5.08, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.